Citation: U. Amon et al., In vitro investigations with the histamine H-1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells, INFLAMM RES, 49(3), 2000, pp. 112-116
Citation: U. Amon et al., In vitro studies with fexofenadine, a new nonsedating histamine H-1 receptor antagonist, on isolated human basophils, INFLAMM RES, 49, 2000, pp. S13-S14
Citation: U. Amon et al., Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis, ACT DER-VEN, 80(4), 2000, pp. 284-286
Citation: U. Amon et al., Pilot study on histamine release from basophils of atopic individuals withlow specific IgE serum levels against casein, INFLAMM RES, 48, 1999, pp. S43-S44
Authors:
Lange, S
Zschocke, I
Langhardt, S
Amon, U
Augustin, M
Citation: S. Lange et al., Effects of combined dermatological and behavioural medicine therapy in hospitalized patients with psoriasis and atopic dermatitis, HAUTARZT, 50(11), 1999, pp. 791-797
Authors:
Augustin, M
Zschocke, I
Lange, S
Seidenglanz, K
Amon, U
Citation: M. Augustin et al., Quality of life in skin diseases: methodological and practical comparison of different quality of life questionaires in psoriasis and atopic dermatitis, HAUTARZT, 50(10), 1999, pp. 715